Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewPF 06650833 is a potent and selective IRAK4 inhibitor (IC50 = 2 nM). Inhibits LPS-induced TNF-α secretion in vivo. Orally bioavailable.
Sold for research purposes under agreement from Pfizer Inc.
分子量 | 361.37 |
公式 | C18H20FN3O4 |
储存 | Store at -20°C |
纯度 | ≥98% (HPLC) |
CAS Number | 1817626-54-2 |
PubChem ID | 118414016 |
InChI Key | JKDGKIBAOAFRPJ-ZBINZKHDSA-N |
Smiles | CC[C@H]1[C@H](NC([C@H]1F)=O)COC2=NC=CC3=C2C=C(C(C(N)=O)=C3)OC |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
参考文献是支持产品生物活性的出版物。
Lee et al (2017) Discovery of clinical candidate 1-{[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a potent, selective inhibitor of interleukin-1 receptor associated kinase 4 (IRAK4) J.Med.Chem. 60 6621 PMID: 28498658
关键词: PF 06650833, PF 06650833 supplier, PF06650833, IRAK4, Interleukin-1, receptor-associated, kinases, potent, selective, orally, bioavailable, IRAK, Cytokines, 6373, Tocris Bioscience
引用文献是使用了 Tocris 产品的出版物。 PF 06650833 的部分引用包括:
Clare E et al (2022) The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways. Cell Rep 40 111225 PMID: 35977521
Jianfeng et al (2022) Interleukin-1 receptor-associated kinase 4 (IRAK4) in the nucleus accumbens regulates opioid-seeking behavior in male rats. Brain Behav Immun 101 37-48 PMID: 34958862
平均评分: 5 (Based on 1 Review.)
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: